Sanofi (SAN) Ordinary Euro 2
Share news, reports & tips
8 September 2021 13:39
(Sharecast News) - Sanofi has agreed to buy Kadmon in a $1.9bn deal, sending shares in the biopharmaceutical company surging.
3 August 2021 13:36
(Sharecast News) - French pharmaceuticals group Sanofi has agreed to buy US clinical stage mRNA therapeutics company Translate Bio in a $3.2bn deal.
19 March 2021 07:50
(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.
22 February 2021 11:05
(Sharecast News) - GlaxoSmithKline and Sanofi have started a new clinical trial into their Cobid-19 vaccine candidate with the aim of refining the dosage.
15 February 2021 12:17
(Sharecast News) - French drug giant Sanofi's two vaccine candidates against Covid-19 may be ready by year-end, the company said, refuting an earlier report.
27 January 2021 16:13
(Sharecast News) - The world's financial stability watchdog warned governments that emergency economic measures needed to be retained in order to stave off the risk of a "correction" in stock...
11 January 2021 08:10
(Sharecast News) - Sanofi has agreed to buy British clinical-stage biopharmaceutical company Kymab for up to $1.45bn.
4 January 2021 12:16
(Sharecast News) - Rolls-Royce's boss said the company would put its UltraFan engine programme on hold when testing ends in 2022 as it waits for new aeroplanes to be developed.
11 December 2020 07:02
(Sharecast News) - G|axoSmithKline and Sanofi have delayed their Covid-19 vaccine programme after their vaccine showed a weak response in people aged 50 and over.
28 October 2020 07:15
(Sharecast News) - Pharmaceutical companies GlaxoSmithKline and Sanofi said they had agreed to make 200m doses of their potential Covid-19 vaccine to a worldwide pooled facility.
18 September 2020 11:01
(Sharecast News) - The European Union agreed an advance purchase agreement with Sanofi and GlaxoSmithKline for the companies' potential Covid-19 vaccine.
3 September 2020 07:03
(Sharecast News) - Sanofi and GSK said they had started a Phase 1/2 clinical trial for Covid-19 vaccine involving 440 people in the US.
Company announcements Announcements
No company announcements about Sanofi Ordinary Euro 2 were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.